With the introduction of the new International Financial Reporting Standard 17 (IFRS 17), financial authorities have prepared guidelines to prevent insurance companies from inflating Contractual Service Margins (CSM) through arbitrary and optimistic actuarial assumptions.In particular, the guideline
SK networks announced on May 31 that it had held an event with the U.S. investment firm Hico Capital and Bow Capital at the Rosewood Sand Hill Hotel in Silicon Valley, California, to advance a partnership. The event was attended by key figures including Vivek Ranadive, chairman of Bow Capital, and C
SK bioscience announced on May 30 that its in-house developed COVID-19 vaccine “Sky Covione” (European name: Sky Covion) has received formal authorization from the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) for primary vaccination (first and second doses) in adults aged 18
The author is an analyst for NH Investment & Securities. He can be reached at junsup@nhqv.com -- Ed.Recently, domestic insurance companies have announced their first IFRS17-based earnings results. However, uncertainties related to accounting principle changes have escalated further. Market participa
On May 25, HanAll Biopharma and Daewoong Pharma announced a joint development agreement on potential treatments for degenerative neurological diseases. The agreement centers on ATH-399A, a leading candidate for Parkinson's disease treatment, currently under development at NurrOn Pharmaceuticals.
The author is an analyst for Shinhan Securities. He can be reached at jaewonjeong@shinhan.com -- Ed.Pharmaceutical/bio sector to rebound in 2H23 on favorable macro conditions and progress in new drug pipelinesPharmaceutical/bio stocks have fallen out of investors’ favor with valuations declining on
Global non-life insurers have been entering the Korean market one after another. The Korean insurance market ranks seventh or eighth in the world.Star International Insurance Singapore is expected to target the Korean travel insurance and accident insurance markets beginning from 2024 if it receives
The author is an analyst for NH Investment & Securities. He can be reached at esshim@nhqv.com -- Ed.As a firm specializing in microneedle RF skin care medical devices, ViOL should enjoy robust earnings growth going forward on: 1) increasing sales of high-margin consumables amid rising demand for cos
The author is an analyst for Shinhan Securities. He can be reached at jhwon@shinhan.com -- Ed.Classys posted consolidated sales of KRW39bn (+10.2% YoY) and operating profit of KRW19.9bn (+19.1% YoY, operating margin of 51.0%) for 1Q23, meeting consensus estimates.Sales of medical aesthetics devices
The author is an analyst of NH Investment & Securities. He can be reached at pk.park@nhqv.com -- Ed.With valuation multiples for the global dental implant industry continuing to rise, we view the key in selecting out investment targets as being market growth potential. Our market estimations analysi
The author is an analyst of NH Investment & Securities. He can be reached at hwdoh@nhqv.com -- Ed.Nvidia products were the top performers in the recent AI benchmark MLPerf. Nvidia's dominance of the AI computing market is likely to continue thanks to both product performance and its platform eco
The author is an analyst of NH Investment & Securities. He can be reached at esshim@nhqv.com -- Ed.As a company specializing in microneedle RF skin care medical devices, ViOL should enjoy robust earnings growth going forward on: 1) increasing sales of high-margin consumables amid rising demand for c
The Korean government will prepare itself for China’s move to weaponize resources such as rare earth elements used throughout high-tech industries. The first step is preemptively securing international standard quality and recycling rare earth elements.As the United States has begun to exclude China
The author is an analyst of NH Investment & Securities. He can be reached at pk.park@nhqv.com -- Ed.We favorably view a rebound in implant exports to China in March, but Suwon City saw disappointing results for 1Q23 on delayed recovery of exports to Russia. In March, aesthetic equipment hit its high
LS Group Chairman Koo Ja-eun has embarked on his first overseas business trip since taking office. The Korean business group has chosen electric vehicles as its future growth driver and is in full swing to reorganize its power infrastructure-oriented group into high-growth businesses such as batteri
A truly postbiotic product containing only postbiotics, which consumers have been eagerly awaiting in their interest in a healthy life, is about to be released in pharmacies.Based on a SCI-level paper by bereum Co., Ltd., formerly known as BeRM, a pharmacist academic symposium was held at Baropharm
Hanwha Life Insurance Indonesia announced on March 29 that it completed the acquisition of a 62.6 percent stake in Lippo General Insurance, a financial subsidiary of Lippo Group, the 6th largest in the Indonesian business world along with Hanwha General Insurance. Hanwha Life Insurance Indonesia acq
The South Korean government announced on March 29 that 22 countries, including the United States, Japan and Taiwan, would be exempted from the Korea Electronic Travel Authorization (K-ETA) requirement going into effect on April 1 this year until Dec. 31, 2024. This measure is to facilitate entry in
Six months ago, the Korea-based medical device manufacturer EOFlow launched a new product in Germany. Now, on March 24, the company faces a patent dispute from the top insulin pump manufacturer in the country and a sales suspension, with no word on when or if they will be able to sell again.EOFlow h
South Korea, China, and Japan are accelerating the growth and development of their pharmaceutical and biotech industries. South Korea’s third five-year national plan to that end was announced on March 24 and China’s first long-term national plan in the sector was announced in May last year.Japan’s p